GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

Oral Tolerability Of Two Nicotine Dosage Forms

Phase 1

Completed

Conditions: Healthy Volunteer Smokers

Interventions: Drug: Nicotine

First Posted Date: 2008-05-22

Last Posted Date: 2013-03-01

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 200

Registration Number: NCT00682461

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416

Phase 1

Terminated

Conditions: Bacterial Infection
Infections, Bacterial

First Posted Date: 2008-05-20

Last Posted Date: 2017-01-20

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 96

Registration Number: NCT00680485

Locations: 🇦🇺
GSK Investigational Site, Adelaide, South Australia, Australia

Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™

Phase 3

Completed

Conditions: Infections, Streptococcal

Interventions: Biological: Pneumococcal vaccine GSK1024850A (Synflorix)
Biological: Prevenar
Biological: GSK Biologicals' Hiberix™

First Posted Date: 2008-05-20

Last Posted Date: 2018-06-08

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 503

Registration Number: NCT00680914

Locations: 🇰🇷
GSK Investigational Site, Wonju-si Kangwon-do, Korea, Republic of

The Effectiveness of Varicella Vaccination in Children in Germany

Completed

Conditions: Chickenpox Vaccines
Varicella (Chickenpox)

Interventions: Procedure: Varicella (chickenpox) lesion sampling

First Posted Date: 2008-05-19

Last Posted Date: 2012-10-29

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 1012

Registration Number: NCT00679796

Locations: 🇩🇪
GSK Investigational Site, Weilheim, Bayern, Germany

Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Rosiglitazone
Drug: Metformin

First Posted Date: 2008-05-19

Last Posted Date: 2018-04-18

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 226

Registration Number: NCT00679939

Locations: 🇪🇸
GSK Investigational Site, Petrer, Spain

An Observational Study For Ambrisentan

Completed

Conditions: Hypertension, Pulmonary

Interventions: Drug: ambrisentan

First Posted Date: 2008-05-16

Last Posted Date: 2017-03-23

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 800

Registration Number: NCT00679224

Locations: 🇬🇧
GSK Investigational Site, Sheffield, United Kingdom

Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1

Phase 3

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Biological: placebo infusion plus physician determined standard of care
Biological: otelixizumab infusion plus physician determined standard of care

First Posted Date: 2008-05-16

Last Posted Date: 2017-10-03

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 272

Registration Number: NCT00678886

Locations: 🇬🇧
GSK Investigational Site, Newcastle upon Tyne, United Kingdom

A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors

Phase 1

Completed

Conditions: Lung Cancer, Non-Small Cell

Interventions: Drug: Pazopanib (GW786034)
Drug: Gemcitabine
Drug: Cisplatin

First Posted Date: 2008-05-16

Last Posted Date: 2017-11-14

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 22

Registration Number: NCT00678977

Locations: 🇬🇧
GSK Investigational Site, Newcastle Upon Tyne, Northumberland, United Kingdom

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Phase 3

Terminated

Conditions: Non-alcoholic Steatohepatitis
Hepatitis C Virus
Chronic Liver Disease
HCV
NASH - Nonalcoholic Steatohepatitis
HIV Infection
Thrombocytopenia
HBV
Human Immunodeficiency Virus
Liver Diseases